4 assets in Anaplastic Oligoastrocytoma

Therapeutic assets addressing Anaplastic Oligoastrocytoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cetuximab Anaplastic Oligoastrocytoma	Northwell Health	P2	CCC (53)
Mannitol Anaplastic Oligoastrocytoma	Northwell Health	P2	CCC (53)
Carboxylesterase-Expressing Allogeneic Neural Stem Cells Anaplastic Oligoastrocytoma	City of Hope Medical Center	P1	CC (43)
Irinotecan Anaplastic Oligoastrocytoma	City of Hope Medical Center	P1	CC (43)